Get your free ETF data sample from our comprehensive offerings. Start your free trial→
Help us improve your experience. Please confirm your investor type:
The Ultimate ETF Comparison Tool - Try Now!
Analyze up to 5 ETFs side-by-side and gain instant insights on performance, fees, holdings, and more to make data-driven investment decisions.
1ARKG ETP · Leverage Shares 1x ARK Genomic Tracker ETP
Performance & flows
Historic performance and flows
| 1M | 3M | 1Y | 3Y | 5Y | MTD | QTD | YTD | ||
|---|---|---|---|---|---|---|---|---|---|
| Perf. | -7.08%  | -11.79% | +19.23%  | -8.53% | N/A | -12.09% | -9.07% | -9.07% | |
| Flows |
Key fund info
Enterprise
Advertisement
Risk profile
Historical risk/return profile
| 3M | 1Y | 3Y | 5Y | |
|---|---|---|---|---|
| Returns | -11.79% | +19.23% | -8.53% | N/A |
| Volatility | ||||
| Perf./Volatility | ||||
| Max drawdown |
Enterprise
Trackinsight Enterprise helps professional and institutional ETF investors tackle operational, regulatory, and analytical challenges at every stage of the investment process.
Learn more about Trackinsight EnterpriseExposure
Enterprise
Trackinsight Enterprise helps professional and institutional ETF investors tackle operational, regulatory, and analytical challenges at every stage of the investment process.
Learn more about Trackinsight EnterpriseSustainability
Enterprise
Trackinsight Enterprise helps professional and institutional ETF investors tackle operational, regulatory, and analytical challenges at every stage of the investment process.
Learn more about Trackinsight EnterpriseIssuer
Frequently asked questions about 1ARKG
What does Leverage Shares 1x ARK Genomic Tracker ETP, 1ARKG, invest in?
1ARKG is a Active ETF. This ETP provides exposure to Other Equities.
What is the Total Expense ratio (TER) of 1ARKG?
1ARKG carries a total expense ratio (TER) of 1.1%, indicating the annual cost for holding the fund.
When was 1ARKG launched?
1ARKG was introduced to the market on December 14, 2021. It trades on Belgium, among other exchanges
Who is the ETF issuer of 1ARKG?
Leverage Shares 1x ARK Genomic Tracker ETP, 1ARKG, is provided by Leverage Shares. Learn more about Leverage Shares here.
What is the current assets under management (AUM) of 1ARKG?
1ARKG oversees €621K in assets as of March 13, 2026.
How has 1ARKG performed lately?
Based on data from March 13, 2026, 1ARKG returned -7.08% over the past month, -11.79% over the last three months and -9.07% year-to-date.
What are the latest inflows or outflows for 1ARKG?
As of March 13, 2026, 1ARKG recorded net flows of +€85K over the last month and +€109K year-to-date.
Does 1ARKG distribute dividends?
1ARKG follows a capitalizing, meaning it reinvests income within the fund.
What is the base currency of 1ARKG?
The base currency of 1ARKG is USD.
Advertisement
About Trackinsight
Since our founding in 2016, we have been at the forefront of the industry, delivering accessible, comprehensive, and reliable tools to support the evolving needs of investors.
Over the past decade, Trackinsight has expanded its operations across six countries, serving thousands of professional investors. We’ve consistently innovated to provide cutting-edge solutions that meet the changing demands of the ETF market.
In 2024, Kepler Cheuvreux, a leading independent European financial services firm, acquired a majority stake in Trackinsight, becoming the company's principal shareholder.
This strategic partnership solidifies Trackinsight's position as a premier provider of ETF selection and analysis tools, while strengthening Kepler Cheuvreux’s commitment to becoming a leading player in the ETF sector.
Together, we are committed to offering advanced services that empower professional investors, advisors, institutions, and issuers. This new step enables us to deliver even more comprehensive and innovative technological solutions, driving ETF investing to new heights.
More about TrackinsightETF TOOLS
PLATFORM
ETF NEWS & RESEARCH
Privacy policy | Cookie policy | | Terms of use | Imprint
